Mary E. Bret
University of Texas Southwestern Medical Center
6 Papers
2 Citations
Mary E. Bret is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Bipolar disorder & Mania. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Language in Alzheimer's disease.
TL;DR: Abnormal articulation and repetition of words were unusual and therefore would not be useful for early detection, but when present, were associated with more advanced disease.
A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
E. Sherwood Brown,S. Domingo Davila,Alyson Nakamura,Thomas J. Carmody,A. John Rush,Alexander Lo,Traci Holmes,Bryon Adinoff,Raul Caetano,Alan C. Swann,Prabha Sunderajan,Mary E. Bret +11 more
TL;DR: Findings suggest that quetiapine does not reduce alcohol consumption in patients with BPD and alcohol dependence.
48
Early behavioral symptoms and course of Alzheimer's disease.
TL;DR: To determine if behavioral symptoms detected at initial evaluation relate to cognitive or functional status or survival time in Alzheimer's disease patients, a large number of patients with AD are receiving sham or symptomatic treatment.
44
A randomized, double-blind, placebo-controlled trial of citicoline for cocaine dependence in bipolar i disorder
E. Sherwood Brown,Jackie Peterson Todd,Lisa T. Hu,Joy M. Schmitz,Thomas J. Carmody,Alyson Nakamura,Prabha Sunderajan,A. John Rush,Bryon Adinoff,Mary E. Bret,Traci Holmes,Alexander Lo +11 more
TL;DR: Cocaine use was significantly reduced with citicoline initially, although treatment effects diminished over time, suggesting the need for augmentation strategies to optimize long-term benefit.
35
Impact of levetiracetam on mood and cognition during prednisone therapy
TL;DR: Levetiracetam was well tolerated when combined with prednisone and showed significant improvement from baseline to exit on RAVLT total words recalled with a non-significant change on other outcomes.
31